Armila was selected to transport the COVID-19 vaccine after interviewing a supplier



[ad_1]

“A provider was interviewed because they had duly fulfilled the contract with the Health Ministry, so we know the provider’s competence,” the center’s response to BNS said on Thursday.

462 thousand The contract with Sotus Harvest for the export of the COVID-19 vaccine to the country’s medical institutions was suspended due to the detection of temperature fluctuations during the transportation of the vaccines.

On January 15, 12 thousand actions with the Armila company were concluded. contracts worth EUR.

According to the ESSC, the value of the contract with Armila is lower due to the lower volume of services.

“The value of the contract is low compared to the other contract, because the volume of services is much lower. The services will be purchased until the maximum value of the contract is reached,” says the response provided by BNS.

Armila is presented as one of the largest international pharmaceutical companies, its main field of activity is the wholesale of pharmaceutical products for pharmacies and hospitals.

Last week, vaccination was temporarily suspended with a shipment of BioNTech and Pfizer vaccines in the Kaunas and Panevėžys regions because the required temperature during the transport of the vaccine could not be guaranteed.

The shipment contained nearly 4.7 thousand. vaccine dose.

The Sotus crop has won the ESSC tender for the vaccine transport, but this vaccine shipment was transported by a subcontractor, the Radusa company.

It is not allowed to publish, quote or reproduce the information of the BNS news agency in the media and on websites without the written consent of the UAB “BNS”.



[ad_2]